EVENT AT NANOLOGICA'S PREMISES – NO DAMAGE TO PERSONNEL OR INSTRUMENTS
Prenumeration
Kalender
| Est. tid* | ||
| 2027-02-25 | 08:10 | Bokslutskommuniké 2026 |
| 2026-11-26 | 08:10 | Kvartalsrapport 2026-Q3 |
| 2026-08-27 | 08:10 | Kvartalsrapport 2026-Q2 |
| 2026-05-29 | N/A | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2026-05-28 | N/A | Årsstämma |
| 2026-05-20 | 08:10 | Kvartalsrapport 2026-Q1 |
| 2026-03-04 | - | Extra Bolagsstämma 2026 |
| 2026-02-26 | - | Bokslutskommuniké 2025 |
| 2025-10-23 | - | Kvartalsrapport 2025-Q3 |
| 2025-07-10 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-23 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2025-05-22 | - | Årsstämma |
| 2025-04-16 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-14 | - | Bokslutskommuniké 2024 |
| 2024-11-08 | - | Kvartalsrapport 2024-Q3 |
| 2024-09-23 | - | Extra Bolagsstämma 2024 |
| 2024-07-05 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-17 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2024-05-16 | - | Årsstämma |
| 2024-04-26 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-09 | - | Bokslutskommuniké 2023 |
| 2023-10-27 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-07 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-05 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2023-05-04 | - | Årsstämma |
| 2023-04-28 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-10 | - | Bokslutskommuniké 2022 |
| 2022-11-11 | - | Kvartalsrapport 2022-Q3 |
| 2022-09-15 | - | Extra Bolagsstämma 2022 |
| 2022-08-19 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-03 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2022-06-02 | - | Årsstämma |
| 2022-04-29 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-08 | - | Bokslutskommuniké 2021 |
| 2021-10-29 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-27 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-28 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2021-05-27 | - | Årsstämma |
| 2021-05-07 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-26 | - | Bokslutskommuniké 2020 |
| 2020-10-30 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-21 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-29 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2020-05-28 | - | Årsstämma |
| 2020-02-26 | - | Extra Bolagsstämma 2020 |
| 2020-02-24 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-07 | - | Bokslutskommuniké 2019 |
| 2019-10-25 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-27 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-31 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2019-05-29 | - | Årsstämma |
| 2019-05-10 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-15 | - | Bokslutskommuniké 2018 |
| 2018-11-23 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-23 | - | Kvartalsrapport 2018-Q2 |
| 2018-06-01 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2018-05-31 | - | Årsstämma |
| 2018-04-25 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-23 | - | Bokslutskommuniké 2017 |
| 2017-11-23 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-25 | - | Kvartalsrapport 2017-Q2 |
| 2017-06-02 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2017-06-01 | - | Årsstämma |
| 2017-05-19 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-23 | - | Bokslutskommuniké 2016 |
| 2016-11-17 | - | Kvartalsrapport 2016-Q3 |
| 2016-09-12 | - | Extra Bolagsstämma 2016 |
| 2016-08-26 | - | Kvartalsrapport 2016-Q2 |
| 2016-06-01 | - | X-dag ordinarie utdelning NICA 0.00 SEK |
| 2016-05-31 | - | Årsstämma |
| 2016-05-20 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-19 | - | Bokslutskommuniké 2015 |
| 2015-11-26 | - | Kvartalsrapport 2015-Q3 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
Over the weekend, a minor explosion occurred in an oven at a company that shares an office and laboratory corridor with Nanologica. The sprinkler system was activated automatically, and water was spread throughout the premises. No one has been injured and Nanologica's equipment is unharmed.
The initial assessment shows that none of Nanologica's instruments or other equipment has been damaged, as water has only spread to Nanologica's premises along the floor. The incident is under control and an investigation is ongoing to determine the exact cause.
Nanologica's large-scale production of silica is unaffected by the incident and measures are being taken to ensure that other work can continue with minimal impact.
For further information, please contact
Johanna Westerberg
Director IR, Communications and Marketing
johanna.johansson@nanologica.com
+46 72 211 21 90
About Nanologica AB (publ)
Nanologica is a Swedish life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. Nanologica’s products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, they can increase productivity and reduce costs for pharmaceutical manufacturers. Nanologica operates in a global niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The Group also includes Syntagon, a contract manufacturer of drug molecules for both clinical studies and commercial delivery. Syntagon works with chemical engineering manufacturing and the development of processes and analyses of pharmaceutical raw materials, with a core competence in small molecules and peptides, and a particular strength in purification and analysis of complex compounds. The Group is headquartered in Södertälje and Nanologica's share (NICA) is listed for trading on Nasdaq Stockholm Main Market. For further information, please visit www.nanologica.com.